NICE Medtech Early Technical Assessment tool to form part of government grant application process for healthcare product developers
The Medtech Early Technical Assessment (META) tool has been selected , as an option, to form part of the application process for a £1million grant for developers of innovative medicines, diagnostics and regulated digital technology in a real world clinical setting,
Latest news headlines
A workshop last month with stakeholders marked the formal start of NICE’s collaborative work to update its 2010 guideline on the diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
15 February 2018
Drug company says it will negotiate terms to allow children to access new treatment for rare genetic disorder
NICE has published draft guidance that does not recommend the drug cerliponase alfa (also called Brineura and made by Biomarin) for children with neuronal ceroid lipofuscinosis type 2 (CLN2) – a very rare inherited condition affecting between 1 and 6 babies each year in the UK.
12 February 2018
NICE has invited Tesaro to submit a proposal for including niraparib (Zejula) in the Cancer Drugs Fund (CDF), for treating some types of recurrent ovarian cancer.
08 February 2018
NICE recommends the use of a more accurate scan to diagnose and determine the stage of pancreatic cancer in patients.
07 February 2018
Up to 1,600 patients with multiple myeloma could benefit from a new oral pill after NICE recommends ixazomib, also known as Ninlaro, for use within the Cancer Drugs Fund (CDF).
07 February 2018
The majority of sore throats do not need antibiotics and medicated lozenges may only help to reduce pain by a small amount, NICE says.
26 January 2018